Comparison guide

Ginkgo, bacopa, lion's mane or huperzine for memory?

Only one of these four has a replicated memory signal, and even that effect is small and takes months to appear. The rest range from a large negative trial (ginkgo) to small pilots (lion's mane) to a drug-like compound backed by poor-quality trials (huperzine A).

The options, compared

Option	Evidence	Best for	The honest note
Ginkgo Biloba	Limited evidence	Not worth taking	The GEM trial gave 3,069 older adults 120 mg twice daily for a median 6.1 years and found no slowing of cognitive decline. It also has antiplatelet activity and case reports of bleeding.	View
Bacopa Monnieri	Moderate evidence	Healthy adults willing to wait	Standardised extract at 300–450 mg/day for at least 12 weeks produced small improvements in free recall and attention speed. Nothing happens acutely, and GI side effects are common unless you take it with food.	View
Lion's Mane Mushroom	Limited evidence	Too early to recommend	The human evidence is a 30-person MCI trial and a small Alzheimer's pilot, and the MCI benefits faded within 4 weeks of stopping. Most products do not declare the compounds that were actually tested.	View
Huperzine A	Limited evidence	Not a supplement to self-dose	It is a potent acetylcholinesterase inhibitor with poor-quality Alzheimer's trials and no good trials in healthy adults. Cholinergic side effects and drug interactions are real, so treat it as a drug, not a nootropic.	View

Our verdict

Bacopa is the only one with a replicated, if modest, memory signal: take a standardised extract with food for 12 weeks before judging it. Skip ginkgo, which failed its largest trial, and lion's mane until better trials exist. Do not take huperzine A without a clinician, especially alongside dementia drugs, beta-blockers or anticholinergics.